Cargando…
K-111: the emerging evidence for its potential in the treatment of the metabolic syndrome
INTRODUCTION: Prevalence of the metabolic syndrome has increased dramatically in recent years. Optimal patient care demands a multifaceted approach, with many individuals requiring several therapies to minimize the significant associated cardiovascular burden. The need for novel agents in the manage...
Autor principal: | Duggan-Keen, Margaret |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321666/ https://www.ncbi.nlm.nih.gov/pubmed/22500152 |
Ejemplares similares
-
Dasatinib: the emerging evidence of its potential in the treatment of chronic myeloid leukemia
por: Haslam, Sonya
Publicado: (2005) -
Eltrombopag: the emerging evidence of its therapeutic value in thrombocytopenia
por: Profit, Louise
Publicado: (2006) -
FTY720 in multiple sclerosis: the emerging evidence of its therapeutic value
por: Thomson, Andrew
Publicado: (2006) -
Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome
por: Waterlow, Mark, et al.
Publicado: (2007) -
Bevacizumab: the evidence for its clinical potential in the treatment of nonsmall cell lung cancer
por: Haslam, Sonya, et al.
Publicado: (2007)